View Post

New research shows breast cancer treatment in patients over age 70 can be safely reduced

In In The News by Barbara Jacoby

Source: University of Pittsburgh From: eurekalert.org Oncologists faced with treating older women with breast cancer often must decide if the treatment may be more detrimental than the cancer. A study published today in JAMA Network Open by researchers at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine sheds new light on this choice and suggests the …

View Post

Trodelvy: Magic bullet for triple-negative breast cancer

In In The News by Barbara Jacoby

By: Ivanhoe Newswire From: winknews.com About 15 percent of all women diagnosed with breast cancer have triple-negative breast cancer, meaning drugs that target estrogen, progesterone, and HER-2 protein—won’t work. In the past, if the cancer returned, patients have had very few options. More on a newly approved drug that is stopping the cancer in its tracks. Jane Ellen Keenan is …

View Post

What to know about oral chemotherapy and breast cancer

In In The News by Barbara Jacoby

From: medicalnewstoday.com Oral chemotherapy is a new type of chemotherapy, or chemo, that people can use at home to treat breast cancer. Chemo historically required a person to go to a doctor’s office or hospital to get an intravenous (IV) infusion or injection. This process could be time-consuming and painful, potentially deterring people from seeking care. As a result of …

View Post

‘Lost in Transition’ After Breast Cancer

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com With more than 4 million breast cancer survivors in the U.S., survivorship care and understanding what happens to patients after surviving is of the utmost importance. An expert explains some side effects survivors may experience and treatments to help. The time after cancer treatment for survivors can sometimes be considered “lost in transition” since patients …

View Post

What Treatment Options Exist for Advanced Breast Cancer?

In In The News by Barbara Jacoby

From: healthline.com Having an advanced form of cancer can feel like you have little or no treatment options. But that’s not the case. Find out what options are available to you and start getting on the right type of treatment. Hormone therapy There are several hormone therapies to treat advanced hormone receptor-positive (estrogen receptor-positive or progesterone receptor-positive) breast cancers: Tamoxifen …

View Post

9 Things You May Not Have Heard from Your Doctor About Breast Cancer

In In The News by Barbara Jacoby

From: healthline.com It can be difficult for others to understand what you’re feeling without going through it themselves. When it comes to breast cancer, your medical team can provide you with a wealth of expert medical advice. But when it comes to the actual experience — how to manage the side effects and long-term insight on your options — some …

View Post

Abemaciclib in HR+/HER2– Advanced Breast Cancer Well-Tolerated With Manageable Adverse Effects

In Clinical Studies News by Barbara Jacoby

By: Vicki Moore, PhD From: oncologynurseadvisor.com A safety analysis of the MONARCH 2 and MONARCH 3 clinical trials suggests that abemaciclib may be generally well tolerated by patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer. Findings of the analysis were reported in the journal The Oncologist. The analysis focused on safety outcomes in …

View Post

How to manage pain medications during breast cancer treatment

In In The News by Barbara Jacoby

By: Health news wires From: journal-news.com Breast cancer researchers have worked tirelessly over the last several decades as they work to eradicate the disease once and for all. While breast cancer still affects millions of women across the globe each year, advancements in treating the disease have dramatically improved five-year survival rates, providing patients and their families with hope as …

View Post

Shorter Trastuzumab Treatment Duration Not Inferior in Breast Cancer Patients

In In The News by Barbara Jacoby

By: Kaitlyn D’Onofrio From: docwirenews.com A study comparing outcomes for breast cancer patients who received one year of adjuvant trastuzumab treatment versus a shorter length of time did not find interior outcomes for the latter group. “The standard adjuvant treatment ERBB2 (formerly HER2 or HER2/neu)-positive breast cancer includes chemotherapy and 1 year of trastuzumab, a recombinant, humanized monoclonal antibody that targets the ERBB2 receptor,” the …

View Post

New NCCN Patient Guidelines Feature Immunotherapy, CAR-T Side Effects

In In The News by Barbara Jacoby

By: Christina Bennett, MS From: cancertherapyadvisor.com The National Comprehensive Cancer Network (NCCN) recently released 2 sets of NCCN Guidelines for Patients® that explain the side effects of different types of immunotherapies. Created for patients with cancer and their caregivers, the guidelines are written in easy-to-understand language and include infographics, definitions of terms, and resources.1,2 Released on June 29, 2020, the …